In this retrospective study employing chart reviews, 75 open heart surgery patients (OHSPs) were divided into 3 groups of 25 patients. Group 1 received no intravenous (IV) norepinephrine (NE) after surgery. Group 2 and group 3 received a minimum of 0.028 mcg/kg/min of IV NE for 6-24 h and greater than 24 h, respectively. In the 3 groups, preoperative lymphocyte counts were compared to counts obtained on postoperative days 1 and 2. The results showed lower lymphocyte counts on postoperative day 2 in group 3 subjects, who received NE for 24 h or more, compared to subjects of the other groups who received no NE or 6-24 h of NE (p < 0.05). There was also evidence that preoperative use of beta-blocking agents significantly affected the change in lymphocyte counts from day 1 to day 2 in both groups receiving NE. Furthermore, postoperative infections were more prevalent in group 3 than the other 2 groups (p < 0.05). The lower lymphocyte counts and higher infection rate, however, may be linked to lower postoperative blood pressure and increased number of intensive care unit days in group 3. Further investigation is warranted to elucidate the effects of IV NE administration on the lymphocyte counts of OHSPs and to reduce infections in those receiving NE.
The past few centuries of man's history have been influenced by the belief that the mind can impact one's health, sickness, and recovery (Weil 1995) . Only, however, during the later half of the 20th century have the studies scientifically linked the nervous and immune systems (Kiecolt-Glaser and others 1996) . It has been discovered that the immune system is linked to the nervous system by sympathetic innervation of the bone marrow, spleen, and lymph nodes (Felten and others 1993) . The lymphocyte, itself, has been shown to have receptors for catecholamines released at the nerve synapse (Aarons and others 1980) . One receptor, the beta-adrenergic receptor, binds the catecholamine norepinephrine (NE) (Carlson and others 1989) .
Recently, investigative efforts have focused on the effects of NE on the immune system and its primary effector cell, the lymphocyte. Studies have determined that NE is a negative regulator of the immune system. That is, NE has been shown to exert its regulatory effects by inhibiting lymphocyte proliferation in the lymph nodes and decreasing migration to the lymph nodes from lymphocyte storage tissues (Madden and others 1993) . This is reflected in a lower circulating lymphocyte count as fewer lymphocytes enter the blood stream from the lymph nodes via efferent lymph vessels. Research on both endogenous and exogenous NE has supported these findings. Research on the effect of endogenous NE on the lymphocyte in open heart surgery patients (OHSPs) has been conducted (Smiley and Vulliemoz 1992) ; however, no published research to date has investigated the effects of IV NE administration on lymphocyte counts and infections in OHSPs, who frequently receive this drug.
Purpose and Research Questions
The purpose of this research was to examine the effects of IV NE infusion on immune status in postoperative cardiac surgery patients. The research specifically investigated the effects of postoperative NE administration on the total number of circulating lymphocytes at postoperative day 1 and day 2, compared to preoperative values. The specific research questions were 1. Are the total numbers of circulating lymphocytes in post-OHSPs reduced by NE administration of a mean dose of 0.028 micrograms per kilogram per minute (mcg/kg/min) or more for 6 to 24 h or greater than 24 h, compared to those OHSPs who did not receive NE? 2. What is the effect of preoperative beta-blocking agent administration on the total number of circulating lymphocytes in OHSPs? 3. What is the effect of NE administration on the rate of infection in OHSPs compared to OHSPs who did not receive NE?
Literature Review
Pioneering studies to identify the physiological mechanism by which the mind and body communicate to mediate the immune system were first documented in academic journals in 1968. Initial identification of the pathway was reported in the discovery that nerve fibers of the autonomic nervous system are prevalent in both primary and secondary lymphoid organs. Further research revealed the bone marrow-a primary lymphoid organ responsible for production and differentiation of immune cells-to have significant innervation by sympathetic noradrenergic nerve fibers. High degrees of innervation in the spleen and lymphatic system-secondary lymphoid organs responsible for storage, maturation, and proliferation of immune cells-were also found (Calvo 1968 ).
Behavioral scientists have spent much effort investigating the effects of stress on immune function in both animals and humans. Studies have shown that stressful situations can negatively affect the immune system, with results ranging from susceptibility to the common cold to increases in tumor growth rate (Sklar and Anisman 1979; Cohen and others 1991) . In studies utilizing the rat, a positive correlation was found between the graded level of stress to which the animal was exposed and the suppression of the mitogen stimulation of the immune cells (Keller and others 1981) . In human studies, the same immunosuppressive effect was found in individuals after prolonged episodes of bereavement and during academic stress experienced by medical students (Schleifer and others 1983; Malarkey and others 1995) .
The results of these and other related psychosomatic studies have been applied to research attempting to alter the immune response in clinical situations in which suppression of the immune system is advantageous. For example, animal studies have used stress induction to decrease the delayed type hypersensitivity reaction to sheep red blood cells (SRBC) and contact sensitivity to the mitogen dinitroflourobenzene (DNFB) (Blecha and others 1982) . In clinical studies, a state of stress was purposefully initiated in skin graft patients by modeling stressfully perceived situations. This resulted in successful alteration of the disease process in graft versus host response (Bovbjerg and others 1982) .
Further delineation of the nervous-immune systems communication used the knowledge that the nervous system communicates via the release of catecholamines from the nerve synapse to the target cells or organs. Immunization of animals with the immune stimulating antigen or mitogen, SRBC, revealed a decrease in NE levels in the spleen during the immune response. This reduction of NE during immune activity inferred that the presence of NE might in fact inhibit the immune cell function. Further experimental results in this study did, in fact, reveal that lowimmune responders are found to have a significantly higher content of NE in the spleen than high responders to the mitogen. The data also revealed a significant increase in splenic weight in high responders, when compared to low responders, from the resultant increase in immune cell content of the spleen in the presence of decreased NE levels (del Rey and others 1982) .
To test whether an increase in lymphocytes is directly related to the decrease in NE release from the nerve synapse, animal studies were conducted in which mice were chemically sympathectomized. That is, the neurotoxic drug 6-hydroxydopamine (6-OHDA) was administered systemically to mice. The noradrenergic nerve terminals were selectively destroyed by this drug, thereby causing depletion in the NE and other catecholamines released to the organs or cells. When the drug-induced sympathectomized mice were compared to a saline-injected control group, the NE content of the lymphoid organs in the sympathectomized group was less than 10% of the control group. The in vivo lymphocyte proliferation of the control and experimental groups was measured by the uptake of injected [ 125 I] deoxyuridine (IUDR) into the DNA of dividing cells. Upon harvest of the animals, the sympathectomized mice exhibited a significant increase in the number of new lymphocytes, measured by radioactivity of the isotope in the spleen, bone marrow, and lymph nodes, suggesting increased cell proliferation in the absence of NE. The inguinal and axillary lymph nodes of the sympathectomized mice displayed an even larger significance of IUDR uptake, as much as 100 times greater than controls, suggesting increased cell migration to these lymph nodes in the absence of NE. This study substantiated the theory that NE exerts a negative regulatory effect on this element of the immune system (Madden and others 1993) .
The ability of NE to affect the lymphoid system was further investigated in research on the lymphocyte itself. Researchers identified the beta-adrenergic receptor (beta-receptor) that corresponds to the noradrenergic catecholamines on the surface of the lymphocyte by using a beta-receptor antagonist, which binds to the receptor sites. Different numbers of these beta-receptors were found on the various subpopulations of the human lymphocytes (Krawietz and others 1982) . These studies suggested that NE might exert stronger control on specific populations of lymphocytes.
Having established a link between NE and the lymphocyte via the beta-receptor, further research was conducted that focused on the relationship of NE to the immune reaction. NE's actual effect on the lymphocyte was investigated through research involving lymphohematopoiesis, in vivo production, and maturation of the lymphocyte. Animal experiments involving the bone marrow, the site of lymphohematopoiesis, revealed that intraosseous addition of NE to mice resulted in a dose-dependent decrease in the proliferation and differentiation of leukocytes. The decrease in lymphocyte proliferation was evident using as low as 10 -8 Molar concentrations of NE and resulted in almost a complete inhibition of lymphocyte differentiation and proliferation at concentrations of 10 -4 molar. This research further supported a regulatory effect of NE on immune cells (Maestroni and Conti 1993 ).
The human model for examining the effects of elevated levels of NE on the immune system for an extended period of time has been the congestive heart failure (CHF) patient. CHF patients have been documented as having elevated levels of circulating catecholamines due to the compensatory action of the autonomic nervous system for controlling blood pressure. These patients have also been documented as immune compromised, suggesting a correlation between these clinical manifestations. To further examine this possible link, the rat animal model was studied by administering NE and other catecholamines for a period of 4 weeks to an experimental group of rats. The results of the NE infusion showed a dosedependent decrease in proliferation of T cells and an overall decrease in the total number of T cells. However, exposure of B cells to a high level of NE for a prolonged period of time actually led to an increase in B cell proliferation and count. This suggested that consistently high levels of NE might lead to immune compromise in CHF patients by down-regulation of the beta-receptor leading to a block in the negative regulatory mechanisms of the cell. This may have caused an inhibition in differentiation of antibodies to specific mitogens due to premature proliferation of B cells.
The OHSP was also used as a model to investigate the effects of exposure to prolonged bursts of NE. The OHSP is exposed to extreme physiological stress while on cardiopulmonary bypass and under the surgical procedure itself. This physiological stress, along with anaesthetic and vasolytic drug use, can result in a very high level of circulating catecholamine levels. Studies to test the effects of this intraoperative stress on the OHSP were conducted. Blood samples from OHSPs were drawn before and after surgery. The samples were then stimulated with a beta-adrenergic agonist, isoproteronol. The cAMP production of the cells was measured to indicate beta-receptor binding and activation. The postsurgical blood when compared to the presurgical blood showed significantly less cAMP when stimulated with isoproteronol, reflecting a decrease in the binding of the receptor. The researchers in this study hypothesized this to be a desensitization of the beta-receptors on the lymphocyte surface (Smiley and Vulliemoz 1992) .
The number of existing beta-receptors on the lymphocyte has been shown in research to be subject to up-regulation as well. Clinical investigation of the administration of beta-adrenergic blocking agents revealed that prolonged exposure of the cells to the beta-blocking agent, propanolol, caused an increase in beta-adrenergic receptors of human lymphocytes. The up-regulation of the beta-receptors was measured at a 43% increase after only 5 days of the drug propanolol. Withdrawal of the drug resulted in a return of the betareceptor count to normal within 24 h (Aarons and others 1980). However, it was hypothesized that patients with beta-receptor up-regulation from chronic betablockade may be highly susceptible to beta-receptor desensitization if the beta-blocking agent is removed and the patient experiences high levels of catecholamine levels from cardiac surgical stress (Smiley and Vulliemoz 1992) .
The exact mechanisms by which the nervous and immune systems interact are very complex in nature. The detailed research in this area has identified many of the probable signaling methods and pathways. An overwhelming amount of literature on the subject has supported the hypothesis that NE is one of its major messengers and the beta-receptor on the lymphocyte is the target for NE's regulatory mechanism. This regulatory mechanism of the lymphocyte by NE appears to be a decrease in migration of lymphocytes to the lymph nodes as well as a decrease in proliferation of these lymphocytes. The result of this negative regulatory mechanism is a decrease in immune activity by lymphocytes in the presence of NE.
Clinical studies involving CHF patients have shown that chronic elevation of endogenous NE may lead to down-regulation of the beta-receptors on the lymphocytes, causing a decrease in immune regulation by NE.
Prolonged bursts of both endogenous and exogenous NE have also been show to affect NE regulation of the lymphocyte by beta-receptor desensitization. Furthermore, beta-receptor blockade resulting from the use of beta-blocking drugs can also influence the betareceptors on the lymphocyte by causing an upregulation of these receptors. It is hypothesized that once the beta-blocking agent is removed, the regulation of the lymphocytes by NE is enhanced due to a greater number of receptor sites. A brief summary of the possible relationship between the NE aspect of the nervous system and lymphocyte portion of the immune system is illustrated in Figure 1 .
Methods
A retrospective chart review was performed in 3 groups of OHSPs:
• Group 1-records from patients who received no IV NE following complications of the surgical procedure; identified as the NO NE group (No NE).
• Group 2-records from patients who received 6 to 24 h of a minimal IV NE dose of 0.028 mcg/kg/min following complications of the surgical procedure; identified as the less than 24-h NE group (<24hr NE).
• Group 3-records from patients who received more than 24 h of a minimal IV NE dose of 0.028 mcg/kg/min following complications of the surgical procedure; identified as the greater than 24-h NE group (>24hr NE).
To ensure that the groups were comparable, the APACHE II, a morbidity and mortality tool (Knaus and others 1985) was used to ensure group similarity in physiological parameters/status immediately prior to surgery. Each group was chosen from a sample of patients with an APACHE II score of 17 or less. All patients were admitted to a cardiovascular ICU immediately postoperative for recovery and remained in the ICU for at least 24 h. Further selection criteria as defined in Table 1 ensured similarities both within and among the 3 groups.
The sample population was selected from an OHSP population of a Level I hospital in southern Arizona.
The selected hospital was a regional medical center responsible for the performance of 35% of cardiac surgeries in the area. The total sample of records from 75 subjects was divided into the 3 groups based on the amount of NE received after surgery. Each group contained 25 individuals, as determined by a sample size power analysis, to produce a power level of 0.82.
For patient selection, a computer search of 1996/1997 hospital records was completed using the appropriate diagnostic-related group (DRG) codes for OHSPs. The computer records revealed a population of 987 patients between the ages of 35 and 75 who had elective open heart surgery and no pharmacy charge for the drug NE. A computer program designed for random sampling randomly selected 45 patients from this group. There were 28 complete charts available for review from the sample. None had an APACHE II score greater than 17 or received NE therapy during his or her hospitalization. Manual random selection of 25 patients produced the sample population for group 1 (No NE). A further computer search of the 1996/1997 hospital records, which matched the appropriate DRG codes to a hospital pharmacy charge for NE, revealed 151 patients between the ages of 35 and 75 who had elective open heart surgery and a pharmacy charge for NE. There were 127 complete charts available for review. Of these patients, 44 were eliminated due to procedures other than valvular repair/replacement or coronary artery bypass, death resulting from surgical complications, or lack of documented NE use. Of the remaining 83 patients, 34 met the selection criteria for group 2, 6 to 24 h of NE infusion (<24h NE) and 26 met the criteria for group 3, greater than 24 h of NE infusion (>24h NE). Of these patients, none had an APACHE II score greater than 17. Manual random selection of 25 patients for each group resulted in the sample population for groups 2 and 3. Hence, the final sample consisted of 75 patients with 25 patients in each group.
The chart reviews included data collection from the history and physical, anesthesia record, operatory report, laboratory records, physician's notes, nurse's notes, drug administration records, and nurse's flow sheets. The demographic data collection included age, sex, weight, diagnosis, surgical procedure, time on bypass, mortality, and complications. The research data for analysis included preoperative complete blood count (CBC) with differential, 1st postoperative morning CBC with differential, and 2nd postoperative morning CBC with differential. Further data collection included length of NE infusion, dose of NE infusion, and other beta agonistic drugs, anti-inflammatory drugs, and postoperative infections.
The NE dose was recorded using the standard method of dosage administration of micrograms per minute and adjusting for variations in weight by dividing the recorded dose by the patients' preoperative weight in kilograms. The total lymphocyte counts from the CBC with differential for each time period was calculated by multiplying the total WBC by the percentage of these cells, which were lymphocytes. Statistical analysis was conducted on the data utilizing various methods of analysis of variance (ANOVA) with multiple comparison corrections to meet the 0.95 confidence level of significance. The probability for significance level was set at p < 0.05.
Results
Each of the 3 groups in this study, group 1 (No NE), group 2 (<24h NE), and group 3 (>24h NE), contained 25 patients who met the criteria for selection in Table  1 . The demographic characteristics, APACHE II scores, and preoperative lymphocyte counts of each group are shown in Table 2 . There was no significant difference between age and APACHE II scores between the groups (p > 0.05). There was, however, a significant difference in the male to female ratio in 204 BIOLOGICAL RESEARCH FOR NURSING Vol. 1, No. 3, January 2000 Table 3 . There was a significant difference in the total number of ICU days among all 3 groups and a significant difference in total number of hospital days for group 3 (>24h NE) when compared to the other 2 groups (p > 0.05). Data collection also included the preoperative and postoperative drug therapy for each patient. The pertinent drugs for this study with the number of patients receiving each drug per group are identified in Table 4 . The basis for treatment with NE for patients in group 2 and group 3 was intraoperative or immediate postoperative hypotension that was unresponsive to initial documented use of dopamine.
There was an overall decrease in the mean circulating lymphocyte count in all 3 groups, with no significant difference between groups on postoperative day 1. There was a significant difference in the mean circulating lymphocyte count on postoperative day 2 for group 3 when compared to groups 1 and 2 (see Fig. 2 ). The percentage of increase in the mean circulating Zziwambazza and others / NE Effects on Lymphocytes 205 lymphocyte count from day 1 to day 2 was also significantly different in groups 1 and 2 when compared to group 3 (see Fig. 3 ).
There was no significant difference between preoperative and postoperative lymphocyte counts within the groups when comparing those who received preoperative beta-blocking agents to those who did not. When taking into consideration the effects of NE on both migration and proliferation, further investigation of the actual change in lymphocyte counts was conducted. Although the actual mean lymphocyte counts revealed no significant difference between beta-blocking agent and non-beta-blocking agent recipients (p > 0.05), there was a significant difference in the percentage change in the lymphocyte counts both within and between groups from day 1 to day 2 (see Table 5 ; p > 0.05). Those who did not receive beta-blocking agents preoperatively had a significantly greater percentage increase in the mean lymphocyte counts in both groups receiving NE. The beta-blocking agent recipients in group 2 (<24 h NE) had a minimal percentage increase in the mean lymphocyte count, whereas group 3 (>24 h NE) had an actual decrease in the mean lymphocyte count. There was also a Table 5 for ranges.) *Significant difference (2-factor ANOVA with replication: p < 0.05).
Figure 3. Mean Percentage Increase in Circulating Lymphocytes from Postoperative Day 1 to Day 2 by Group.
Twenty-five subjects in each group. Ranges: group 1 (51%-95%), group 2 (11%-59%), group 3 (-12%-28%). Because there was no significant variation of NSAID, steroid, or postoperative beta-blocking agent use among the groups (1-way ANOVA, p > 0.05), these data were not presented. Additionally, there was no significant difference within or between the groups in lymphocyte counts when comparing the preoperative diagnosis of CHF to other diagnoses (1-way ANOVA, p > 0.05); therefore, these data were also not presented.
There was a significant difference (1-way ANOVA, p > 0.05) in documented postoperative infection between group 3 (>24h NE) and the other 2 groups (see Fig. 4 ). Postoperative infection was identified by a positive laboratory culture for bacterial presence within 5 days of surgery and documentation by the physician in the progress notes. The time frame for infection was limited to allow for the earlier discharge time of the No NE group and other infectious exposure besides surgery.
Discussion
The findings of this study are consistent with the hypothesis that NE infusion can alter the circulating lymphocyte counts of OHSPs. The results suggest beta-blocking drugs given preoperatively may affect both endogenous and exogenous regulation of lymphocytes. Also, these findings are consistent with increased infections in this population with NE infusion. However, the findings related to NE and lymphocyte counts causing a direct effect on increased infection rates in group 3 are not conclusive due to differences in linked variables in group 3 compared to the other 2 groups, namely, sex, low blood pressure complications, and ICU days.
The extraneous variables that may have affected the results were attempted to be controlled by following the selection criteria in Table 1 and prescreening all subjects with the APACHE II tool. However, a number of variables were not able to be addressed using the chart review format. There are some identified differences in the sample characteristics of each group that may have affected some results. The fewer number of females in group 2 (<24h NE) may have affected the mean lymphocyte counts in this group compared to the other 2 groups. Although there is no difference in the documented standard lymphocyte counts between men and women, there may be some differences in the immune reaction process between the sexes, because hormones affect production, storage, and release of lymphocytes. Additionally, hypotension may also have been a risk factor creating increased levels of endogenous NE and cytokines, which may have affected lymphocyte counts in groups 2 and 3.
The postoperative characteristics revealed a significant difference in both total ICU days and total hospital days. Because all documented infections were recorded by the 5th postoperative day, it is doubtful that the increased number of total hospital days contributed to a higher infection rate of group 3 (>24h NE). However, an increased number of ICU days has been linked to higher infection rates (Nicholls 1997) and may have had some influence within this group.
The mean circulating lymphocyte count of all 3 groups was lower on both postoperative day 1 and day 2 than the preoperative value. This could be related to the postoperative inflammation process causing a migration of immune cells to the surgical sites and surrounding tissue (Quinn and Shannon 1975) as well as increased cortisol levels from surgical stress causing a reduction in lymphocyte production (Smiley and Vulliemoz 1992) . The mean postoperative day 2 lymphocyte count was relatively higher in all 3 groups when compared to day 1 (see Fig. 2 ). This relative increase in circulating lymphocytes may be explained by 2 distinct events:
An overall increase in the total number of lymphocytes due to proliferation, and An influx of lymphocytes back into circulation from the tissue via lymph vessels after migration to the lymph nodes (Quinn and Shannon 1975) The mean percentage increase in circulating lymphocytes from day 1 to day 2 was lower in both of the NE groups than the No NE group. Group 3 (>24h NE) had a significantly lower count than either of the other 2 groups (see Table 6 ). Because NE negatively regulates both proliferation and migration of lymphocytes, the administration of exogenous NE may have contributed to a decrease in these activities in both NE groups. The significant difference in group 3 (>24h NE) could be due to the significantly higher dosage of NE used in this group along with the increased time that the drug was used.
When comparing the patients receiving betablocking agents preoperatively to those who did not, the trend in all 3 groups can be seen in Table 5 . All patients receiving beta-blocking agents preoperatively had a significant difference in the percentage change in circulating lymphocytes from day 1 to day 2 within the group, when compared to the non-beta-blocking agent patients. This smaller percentage change was mainly caused by a higher mean circulating lymphocyte count on day 1 in the beta-blocking agent patients of each group. This resulted in a relatively smaller increase in the mean circulating lymphocyte count of betablocking agent recipients in group 1 and 2 on day 2 and an actual decrease in the mean lymphocyte count of beta-blocking agent recipients in group 3 on day 2.
The significantly higher rate of infection among patients in group 3 (>24h NE) (see Fig. 4 ) may have a positive correlation to the lower lymphocyte counts in these patients. All of the patients in group 3 with a documented postoperative infection, n = 20, received only 2 days of antibiotic therapy postoperatively (see Table 3 ). However, 3 of the patients in group 3, who had no documented postoperative infection before discharge from the hospital, received 4 or more days of prophylactic antibiotic therapy postoperatively. This intervention may have influenced the results.
Applications of this research would require more in-depth research to isolate the effects of NE dose, decreased blood pressure, and number of ICU days on lymphocyte counts and infection rates in OHSPs. However, the ICU nurse might positively affect the outcome of OHSPs by closely monitoring changes in lymphocyte counts and antibiotic therapy orders of patients exhibiting a profile of increased risk for infection. This study has been beneficial in the identification of one such patient profile. Patients requiring IV NE doses of greater than 0.028 mcg/kg/min for more than 24 h due to hypotension after open heart surgery may indeed be at a higher risk for infection as determined by this study. When applying this study to the assessment of such a patient, the nurse may wish to consider a total circulating lymphocyte count of less than 1100 on postoperative day 2 (see Fig. 2 ) as an indicator of the increased risk of infection. Additionally, preoperative use of beta-blocking agents may also be considered in the patient with this profile.
Limitations
Since the sample size was limited, N = 75, and the data were collected from only one hospital, caution should be taken before applying these results to all patients. Other limitations to this study include both the variation in preoperative differential counts, manual versus automated, and the inability to measure or control endogenous NE levels in these patients. Further research should be done to confirm this study using several hospitals in different regions for data collection and including a larger patient population. (n = 7) (n = 9) (n = 10) NOTE: Results are mean percentage ± SD. n = number of subjects on drug. NE = norepinephrine. a. significant difference within groups (2-factor ANOVA without replication: p < 0.05). b. significant difference between groups (2-factor ANOVA without replication: p < 0.05).
